Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127525761 | 12752576 | 1 | I | 20100908 | 20110607 | 20160916 | 20160916 | EXP | US-ROCHE-783504 | ROCHE | 80.00 | YR | F | Y | 0.00000 | 20160916 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127525761 | 12752576 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 10 MG/KG?OVER 30 TO 90 MIN ON DAYS 1 AND 15 (28 DAYS CYCLE)?LAST DOSE PRIOR TO SAE: 31 AUGUST 2010 | U | 125085 | 1400 | MG | SOLUTION FOR INFUSION | ||||||
| 127525761 | 12752576 | 2 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | 610 | MG | ||||||||
| 127525761 | 12752576 | 3 | SS | Bevacizumab | BEVACIZUMAB | 1 | U | 125085 | |||||||||||
| 127525761 | 12752576 | 4 | SS | Bevacizumab | BEVACIZUMAB | 1 | U | 125085 | |||||||||||
| 127525761 | 12752576 | 5 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | 25 MG?DAYS 1, 8, 15, 22 (28 DAY CYCLE)?LAST DOSE PRIOR TO SAE: 31 AUGUST 2010 | U | 0 | 100 | MG | |||||||
| 127525761 | 12752576 | 6 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | U | 0 | 25 | MG | ||||||||
| 127525761 | 12752576 | 7 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | U | 0 | |||||||||||
| 127525761 | 12752576 | 8 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | U | 0 | |||||||||||
| 127525761 | 12752576 | 9 | SS | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 127525761 | 12752576 | 10 | C | COMPAZINE | PROCHLORPERAZINE MALEATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127525761 | 12752576 | 1 | Endometrial cancer |
| 127525761 | 12752576 | 2 | Ovarian cancer |
| 127525761 | 12752576 | 3 | Malignant neoplasm of islets of Langerhans |
| 127525761 | 12752576 | 4 | Hepatocellular carcinoma |
| 127525761 | 12752576 | 5 | Endometrial cancer |
| 127525761 | 12752576 | 6 | Hepatocellular carcinoma |
| 127525761 | 12752576 | 7 | Malignant neoplasm of islets of Langerhans |
| 127525761 | 12752576 | 8 | Ovarian cancer |
| 127525761 | 12752576 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127525761 | 12752576 | OT |
| 127525761 | 12752576 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127525761 | 12752576 | Anaemia | |
| 127525761 | 12752576 | Ileus | |
| 127525761 | 12752576 | Infection | |
| 127525761 | 12752576 | Small intestinal obstruction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |